Diag Bronchiolitis

download Diag Bronchiolitis

of 2

Transcript of Diag Bronchiolitis

  • 7/28/2019 Diag Bronchiolitis

    1/2

    2. Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR.Chickenpox outbreak in a highly vaccinated school population. Pediatrics2004;113:455-9.3. Galil K, Lee B, Strine T, Carraher C, Baughman AL, Eaton M, et al.Outbreak of varicella at a day-care center despite vaccination. N Engl J Med2002;347:1909-15.

    Management and outcomes of care of fever inearly infancy

    PANTELL RH, NEWMAN TB, BERNZWEIG J, BERGMAN DA, TAKAYAMA JI,

    SEGAL M, ET AL. JAMA 2004;291:1203-12

    Context Fever in infants challenges clinicians to distinguish

    between serious conditions, such as bacteremia or bacterial

    meningitis, and minor illnesses. To date, the practice patterns

    of office-based pediatricians in treating febrile infants and the

    clinical outcomes resulting from their care have not been

    systematically studied.

    Objectives To characterize the management and clinical

    outcomes of fever in infants, develop a clinical prediction

    model for the identification of bacteremia/bacterial meningitis,

    and compare the accuracy of various strategies.Design Prospective cohort study.

    Setting Offices of 573 practitioners from the Pediatric

    Research in Office Settings (PROS) network of the American

    Academy of Pediatrics in 44 states, the District of Columbia,

    and Puerto Rico.

    Participants Consecutive sample of 3066 infants aged 3

    months or younger with temperatures of at least 388C seen

    by PROS practitioners from February 28, 1995, through April

    25, 1998.

    Main outcome measures Management strategies, illness

    frequency, and rates and accuracy of treating bacteremia/

    bacterial meningitis.

    Results The PROS clinicians hospitalized 36% of the infants,

    performed laboratory testing in 75% (74% with complete blood

    cell count or blood culture; 54% with urine testing; 33% with

    lumbar punctures), and initially treated 57% with antibiotics.

    The majority (64%) were treated exclusively outside of the

    hospital. Bacteremia was detected in 1.8% of infants (2.4% of

    those tested) and bacterial meningitis in 0.5%. Well-appearing

    infants aged 25 days or older with fever of

  • 7/28/2019 Diag Bronchiolitis

    2/2

    Objectives To review the data on diagnostic and supportive

    testing in the management of bronchiolitis and to assess the

    utility of such testing.

    Design Systematic review of studies addressing diagnostic

    and supportive testing for bronchiolitis.

    Main outcome measures Sensitivity and specificity of

    various diagnostic tests, and impact of these tests on clinical

    outcome.

    Study identification In conjunction with an expert panel, the

    authors derived relevant terms to search the literature

    published from 1980 to November 2002 in MEDLINE and the

    Cochrane Collaboration Database of Controlled Clinical Trials.

    Studies reviewed Of the 797 abstracts identified, 82 trials

    met the authors inclusion criteria (17 are primary articles on

    diagnosis of bronchiolitis and 65 are reports of treatment or

    prevention trials).

    Results Numerous studies demonstrate that rapid RSV tests

    have acceptable sensitivity and specificity, but no data show

    that RSV testing affects clinical outcomes in typical cases of the

    disease. Seventeen studies presented chest radiographic film

    data. Abnormalities on chest radiographs ranged from 20% to

    96%. Insufficient data exist to show that chest radiographs

    reliably distinguish between viral and bacterial disease or

    predict severity of disease. Ten studies included complete

    blood cell counts, but most did not present specific results. In

    one study, white blood cell counts correlated with radiologi-

    cally defined disease categories of bronchiolitis.

    Conclusions A large number of studies include diagnostic and

    supportive testing data. However, these studies do not define

    clear indications for such testing or the impact of testing on

    relevant patient outcomes. Given the high prevalence of

    bronchiolitis, prospective studies of the utility of such testing

    are needed and feasible.

    Comment Bronchiolitis is one of the most common child-

    hood diseases and has been variably diagnosed over decades

    with differing sobriquets such as infectious asthma, wheezy

    bronchitis, and infectious bronchitis. Nevertheless, no gold

    standard exists for its diagnosis. With our current technologic

    advances, the diagnosis of this clinical entity has become

    increasingly laboratory-based, but not evidence-based, accord-

    ing to Bordley et al.

    Over 12 years only 82 trials met the inclusion criteria for their

    review, and presumably there would have been fewer if they

    had limited the age to that usually applied to the diagnosis ofbronchiolitisthe first two years of life. Of these studies,

    diagnosis was the primary focus of only 17, and none evaluated

    the usefulness of supportive testing in diagnosing bronchiolitis.

    The other 65 studies were primarily on treatment and

    prevention but contained some data on diagnosis and testing.

    The included populations, however, had differing or poorly

    defined inclusion criteria. Most required an etiologic diagnosis,

    but none asked or answered whether knowing RSV to be the

    cause affected the clinical outcome. Most focused on disease

    severity assessed by clinical scales, the reliability of which may

    be more dependent on the assessor than what is assessed.

    Bordley et al, recognizing these differences and deficits,

    concluded that the studies did not define clear indications

    for such testing or for the impact of testing on relevant patient

    outcomes. This may be interpreted, though incorrectly in my

    opinion, as evidence against the use of supportive diagnostic

    testing. One may conclude that specific or supportive testing in

    managing bronchiolitis seems unlikely to be beneficial for most

    children, but may be warranted in individual circumstances,

    which currently are not able to be defined. Second, the bestdiagnostic method currently available is the test of time,

    performed by an experienced clinician. Third, this analysis

    substantiates the authors suggestion that prospective trials of

    the value of such testing are needed. However, although they

    state that such studies are feasible, they do not define how todo

    them. The design, implementation, and funding of such a trial

    will I hope bethe subject of a futurepublication fromthisgroup.

    Caroline Breese Hall, MDDepartments of Pediatrics and Medicine, Infectious Diseases

    University of Rochester, School of Medicine and DentistryRochester, NY 14642

    Otitis media and speech and language:A meta-analysis of prospective studies

    ROBERTS JE, ROSENFELD RM, ZEISEL SA. PEDIATRICS 2004;113:e238-48

    Context Considerable controversy surrounds whether a his-

    tory of otitis media with effusion (OME) in early childhood

    causes later speech and language problems.

    Objectives Todetermine(1) whether a historyof OMEin early

    childhood is related to receptive language, expressive language,

    vocabulary, syntax, or speech development in children 1 to 5

    years of age; and (2)whether hearing loss causedby otitis media

    in early childhood is related to childrens receptive language or

    expressive language through 2 years of age.

    Design Systematic review of prospective studies examining

    how OME in early childhood relates to later speech and

    language skills.

    Main outcome measures Speech and language outcomes in

    children tested between 1 and 5 years of age.

    Study identification The authors searched online databases

    and bibliographies of OME studies and reviews for prospective

    or randomized clinical trials published between January 1966

    and October 2002 that examined the relationship of OME or

    OME-associated hearing loss in early childhood to childrens

    later speech and language development.

    Studies reviewed Of the 38 studies identified, 14 had data

    suitable for calculating a pooled correlation coefficient

    (correlational studies) or standard difference between parallel

    groups (group studies).

    Results There were no significant findings for the analyses of

    OME during early childhood versus receptive or expressive

    language during the preschool years in the correlation studies.

    Similarly, there were no significant findings for OME versus

    vocabulary, syntax, or speech during the preschool years.

    Conversely, there was a significant negative association

    between OME and preschoolers receptive and expressive

    language (lower language, 0.24 and 0.25 standard difference,

    respectively) in the group studies. In addition, hearing was also

    418 Clinical Research Abstracts for Pediatricians The Journal of Pediatrics September 2004